Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

6.10
Delayed Data
As of 4:00pm ET
 -0.21 / -3.33%
Today’s Change
5.25
Today|||52-Week Range
16.40
+8.93%
Year-to-Date
Can The Uptrend Continue for uniQure N.V. (QURE)?
Feb 14 / Zacks.com - Paid Partner Content
Will Uniqure (QURE) Continue to Surge Higher?
Feb 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close6.31
Today’s open6.43
Day’s range6.04 - 6.41
Volume185,868
Average volume (3 months)263,150
Market cap$158.7M
Dividend yield--
Data as of 4:00pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)-25.40%
Earnings growth (this year)+15.95%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+68.18%
P/E ratio--
Price/Sales34.95
Price/Book1.18

Competitors

 Today’s
change
Today’s
% change
FATEFate Therapeutics In...+0.45+11.45%
VBLTVascular Biogenics L...+0.20+3.57%
ASTAsterias Biotherapeu...-0.05-1.35%
NVIVInVivo Therapeutics ...+0.10+2.25%
Data as of 4:00pm ET, 02/21/2017

Financials

Next reporting dateApril 10, 2017
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$10.5M
Annual profit (last year)-$79.3M
Net profit margin-758.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Executive Director
Matt Kapusta
Chief Operating Officer
Eric Goossens
Corporate headquarters
Amsterdam, Noord-holland

Forecasts


Search for Jobs